Literature DB >> 22682899

Nesfatin-1(30-59) but not the N- and C-terminal fragments, nesfatin-1(1-29) and nesfatin-1(60-82) injected intracerebroventricularly decreases dark phase food intake by increasing inter-meal intervals in mice.

Andreas Stengel1, Miriam Goebel-Stengel, Lixin Wang, Ikuo Kato, Masatomo Mori, Yvette Taché.   

Abstract

Nesfatin-1 is an 82 amino acid N-terminal fragment of nucleobindin2 that was consistently shown to reduce dark phase food intake upon brain injection in rodents. We recently reported that nesfatin-1(1-82) injected intracerebroventricularly (icv) reduces dark phase feeding in mice. Moreover, intraperitoneal injection of mid-fragment nesfatin-1 (nesfatin-1(30-59)) mimics the food intake-reducing effects of nesfatin-1(1-82), whereas N-terminal (nesfatin-1(1-29)) and C-terminal fragments (nesfatin-1(60-82)) did not. We therefore characterized the structure-activity relationship of nesfatin-1 injected icv to influence the dark phase meal pattern in mice. Mouse nesfatin-1(1-29), nesfatin-1(30-59), nesfatin-1(60-82) or vehicle was injected icv in freely fed C57Bl/6 mice immediately before the dark phase and food intake was monitored using an automated episodic feeding monitoring system. Nesfatin-1(30-59) (0.1, 0.3, 0.9 nmol/mouse) induced a dose-related reduction of 4-h food intake by 28%, 49% and 49% respectively resulting in a 23% decreased cumulative 24-h food intake compared to vehicle at the 0.3 nmol/mouse dose (p<0.05). The peak reduction occurred during the 3rd (-96%) and 4th hour (-91%) post injection and was associated with a reduced meal frequency (0-4h: -47%) and prolonged inter-meal intervals (3.1-times) compared to vehicle (p<0.05), whereas meal size was not altered. In contrast, neither nesfatin-1(1-29) nor nesfatin-1(60-82) reduced dark phase food intake at equimolar doses although nesfatin-1(60-82) prolonged inter-meal intervals (1.7-times, p<0.05). Nesfatin-1(30-59) is the active core of nesfatin-1(1-82) to induce satiety indicated by a reduced meal number during the first 4h post injection. The delayed onset may be indicative of time required to modulate other hypothalamic and medullary networks regulating nocturnal feeding as established for nesfatin-1. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682899      PMCID: PMC3372867          DOI: 10.1016/j.peptides.2012.03.015

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  19 in total

1.  Intracerebroventricular CART peptide reduces rat ingestive behavior and alters licking microstructure.

Authors:  S Aja; G J Schwartz; M J Kuhar; T H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-06       Impact factor: 3.619

2.  A new way of looking at eating.

Authors:  Nori Geary
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06       Impact factor: 3.619

Review 3.  Brainstem mechanisms integrating gut-derived satiety signals and descending forebrain information in the control of meal size.

Authors:  Hans-Rudolf Berthoud; Gregory M Sutton; R Leigh Townsend; Laurel M Patterson; Huiyuan Zheng
Journal:  Physiol Behav       Date:  2006-09-25

4.  Nesfatin-1 exerts long-term effect on food intake and body temperature.

Authors:  K Könczöl; O Pintér; S Ferenczi; J Varga; K Kovács; M Palkovits; D Zelena; Z E Tóth
Journal:  Int J Obes (Lond)       Date:  2012-01-31       Impact factor: 5.095

5.  Structural and molecular evolutionary analysis of Agouti and Agouti-related proteins.

Authors:  Pilgrim J Jackson; Nick R Douglas; Biaoxin Chai; Jonathan Binkley; Arend Sidow; Gregory S Barsh; Glenn L Millhauser
Journal:  Chem Biol       Date:  2006-12

6.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Authors:  Shinsuke Oh-I; Hiroyuki Shimizu; Tetsurou Satoh; Shuichi Okada; Sachika Adachi; Kinji Inoue; Hiroshi Eguchi; Masanori Yamamoto; Toshihiro Imaki; Koushi Hashimoto; Takafumi Tsuchiya; Tsuyoshi Monden; Kazuhiko Horiguchi; Masanobu Yamada; Masatomo Mori
Journal:  Nature       Date:  2006-10-01       Impact factor: 49.962

7.  Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism.

Authors:  H Shimizu; S Oh-I; K Hashimoto; M Nakata; S Yamamoto; N Yoshida; H Eguchi; I Kato; K Inoue; T Satoh; S Okada; M Yamada; T Yada; M Mori
Journal:  Endocrinology       Date:  2008-10-16       Impact factor: 4.736

8.  Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.

Authors:  Vicente Martínez; Lixin Wang; Jean Rivier; Dimitri Grigoriadis; Yvette Taché
Journal:  J Physiol       Date:  2004-01-30       Impact factor: 5.182

9.  Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-27       Impact factor: 3.619

10.  Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Nils W G Lambrecht; Yvette Taché
Journal:  Endocrinology       Date:  2009-10-01       Impact factor: 4.736

View more
  20 in total

1.  Islet β-cell-produced NUCB2/nesfatin-1 maintains insulin secretion and glycemia along with suppressing UCP-2 in β-cells.

Authors:  Yifei Yang; Boyang Zhang; Masanori Nakata; Jun Nakae; Masatomo Mori; Toshihiko Yada
Journal:  J Physiol Sci       Date:  2019-06-21       Impact factor: 2.781

2.  Nesfatin-1 suppresses gastric contractions and inhibits interdigestive migrating contractions in conscious dogs.

Authors:  Akira Watanabe; Erito Mochiki; Akiharu Kimura; Norimichi Kogure; Mitsuhiro Yanai; Atsushi Ogawa; Yoshitaka Toyomasu; Kyoichi Ogata; Tetsuro Ohno; Hideki Suzuki; Hiroyuki Kuwano
Journal:  Dig Dis Sci       Date:  2015-01-07       Impact factor: 3.199

3.  Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis.

Authors:  A Stengel; Y Taché
Journal:  Horm Metab Res       Date:  2013-09-18       Impact factor: 2.936

4.  Gastric peptides and their regulation of hunger and satiety.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Gastroenterol Rep       Date:  2012-12

Review 5.  The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors.

Authors:  A Stengel; M Mori; Y Taché
Journal:  Obes Rev       Date:  2013-08-27       Impact factor: 9.213

Review 6.  Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-12-12       Impact factor: 3.633

7.  Long-term infusion of nesfatin-1 causes a sustained regulation of whole-body energy homeostasis of male Fischer 344 rats.

Authors:  Sima Mortazavi; Ronald Gonzalez; Rolando Ceddia; Suraj Unniappan
Journal:  Front Cell Dev Biol       Date:  2015-04-08

8.  Expression of Nesfatin-1/NUCB2 in Fetal, Neonatal and Adult Mice.

Authors:  Yiwa Chung; Eunhye Jung; Heejung Kim; Jinhee Kim; Hyunwon Yang
Journal:  Dev Reprod       Date:  2013-12

9.  Nesfatin-1 as a new potent regulator in reproductive system.

Authors:  Jinhee Kim; Hyunwon Yang
Journal:  Dev Reprod       Date:  2012-12

10.  Ablation of neurons expressing melanin-concentrating hormone (MCH) in adult mice improves glucose tolerance independent of MCH signaling.

Authors:  Benjamin B Whiddon; Richard D Palmiter
Journal:  J Neurosci       Date:  2013-01-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.